HQY vs SYK: fair value comparison
HealthEquity, Inc. and Stryker Corporation · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, SYK currently sits closer to the top of our discount ranking. SYK carries the stronger quality grade.
| HQY | SYK | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $104.36 | $303.13 |
| 12-month range | $77.93–$104.36 | $294.73–$387.02 |
| Sector rank | #22 of 113 Healthcare | #21 of 113 Healthcare |
| Quality grade | C | A |
| Momentum grade | A | — |
| Leverage | Low | Moderate |
| Margin trend | — | Stable |
| Revenue growth | — | Strong |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: HQY fair value analysis · SYK fair value analysis